Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-24 @ 2:01 PM
Ignite Modification Date:
2025-12-25 @ 12:46 PM
NCT ID:
NCT04303195
Population Description:
This study included a Screening Period of up to 6 weeks and a 2-week Pretreatment Period. Following successful completion of the Pretreatment Period, participants eligible for the clinical study were randomized in a 1:1:1:1 ratio to receive either NG101 5 mg, 10 mg, or 20 mg, or matching placebo during a 12-week Treatment Period.
Study:
NCT04303195
Study Brief:
Results Section:
NCT04303195